GSTM1 and hepatocellular carcinoma: The results presented here show that Cur@Hb nanoparticles could inhibit hepatoma migration and vascular mimics, and enhance the radiosensitivity of hypoxic hepatoma cells via repressing cell proliferation and DNA damage repair, as well as inducing apoptosis in vitro.